Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-22
1994-04-05
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31495, A61K 3150
Patent
active
053005040
ABSTRACT:
A compound selected from the group consisting of those having the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.4 are independently selected from the group consisting of H and alkyl radicals containing 1 to 4 carbon atoms, R.sub.2 and R.sub.3 are independently selected from the group consisting of H, OXO, and alkyl radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R.sub.5, R.sub.6 and R.sub.7 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as alteration in the rate of fluid transport in the gastrointestinal tract, reduction in intraocular pressure, and increase in renal fluid flow.
REFERENCES:
patent: 5077292 (1991-12-01), Gluchowski
patent: 5112822 (1992-05-01), Gluchowski
Pieter, et al, "Clonidine and Some Bridge Analogues; Cardiovascular Effects & Nuclear Magnetic Resonance Date (1H/.sup.13)", Eur. J. Med. Chem., Jul.-Aug. (1980), vol. 4, pp. 323-329.
Jarrot, "Clonidine and Related Compounds", Hardbook of Hypertension, vol. 5, (1984).
Zwieten et al, "Central & Periphera .alpha.-Adrenoceptors. Pharmacological Aspects & Clinical Potential", Advances in Drug Research vol. 13, (1984) (209-254).
Bloor et al, "Reduction in Halothane Anesthetic Requirement by Clonidine, an Alpha-Adrenergic Agonist", Anesthesia & Analgesia, vol. 61, No. 9, (Sep. 1982) (741-745).
.alpha.2-Adrenergic Agonists; A Newer Class of Anbtidiarrheal Drug Gastroenterology (1986) vol. 91, pp. 769-775.
Langer et al, "Pharmacologic & Therapeutic Significance of .alpha.-Adrenoceptor Subtypes", Journal of Cardiovascular Pharmacology, vol. 7, Supp. 8 (S1-S8), (1985).
Nielsen et al, "Postjunctional .alpha..sub.2 adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels" Br. J. Pharmacol (1989), 97, (829-834).
B. Bloor, "Clonidine & Other Alpha.sub.2 Adrenergic Agonists: An Important New Drug Class for the Perioperative Period", Seminars in Anesthesia, vol. VII, No. 3 (Sep.) (1988) (pp. 170-177).
Sato et al, "Adrenergic Excitation of Cutaneous Pain Receptors Induced by Peripheral Nerve Injury", Science, vol. 251, (Mar.), (1991), pp. 1608-1610.
Bendele, et al, "Anti-Inflammatory Activity of Pergolide in Rats", Pharmacol (Aug.) (1991), (p. 152), 82.
Hieble, et al, "A Potent Peripherally Acting, .alpha..sub.2 Adrenoceptor Agonist", The Pharmologist (1991), vol. 33, #3 (p. 214).
The Pharmacological Basis of Therapeutics, Gilman & Goodman, (1985), "Therapeutic Uses of Sympathomimetic Drugs", (pp. 174-179), 7th Edition, Chapter 8.
Ekas et al, Increased presynaptic alpha-adrenoceptor mediated regulation of spontaneously hypertensive rats, Chemical Abstracts, vol. 98, No. 1, (Jan. 3, 1983), p. 918.
De Mey et al, Differences in pharmacological properties of postjunctional alpha-adrenergic receptors among arteries and veins, Chemical Abstracts, vol. 93, No. 13, (Sep. 29, 1980), p. 96.
Walland, Inhibition of a somato-sympathetic reflex via peripheral presynaptic alpha-adrenoceptors, Chemical Abstracts, vol. 88, No. 23, (Jun. 5, 1978) p. 80.
C. F. Colpaert, Maximal magnitude of effect and potency of putative alpha-adrenoceptor agonists in causing CNS depression, in relaxing muscle, and in lowering body temperature in rat, Chemical Abstracts, vol. 105, No. 1, (Jul. 7, 1986), p. 45.
Philippu et al, Changes in the arterial blood pressure increase the release of endogenous histamine in the hypothalamus of anesthetized cats, Chemical Abstracts, vol. 99, No. 15, (Oct. 10, 1983), p. 137.
Ekas et al, Presynaptic alpha- and beta-adrenoceptor stimulation andnorepinephrine release in the spontaneously hypertensive rat, Chemical Abstracts, vol. 98, No. 25, p. 109, (1983).
Steppler et al, Pre- and postsynaptic effects of phenylephrine and tramazoline on blood vessels in vivo, Chem. Abstracts, vol. 91, No. 21, (Nov. 19, 1979), p. 43.
Steppeler et al, A comparison of pre- and postsynaptic alpha-adrenergic effects of phenylephrine and tramazoline on blood vessels of the rabbit in vivo, Chem. Abstracts, vol. 90, No. 5, (Jan. 29, 1979), p. 37.
Timmermans et al, Hypotensive and bradycardic effects of classical alpha-sympathomimetic drugs upon intravenous administration to pentobarbiton-anesthetized rate, Chem. Abstract, vol. 89, No. 1, (Jul. 3, 1978), p. 49.
Boudier et al, Central and peripheral alpha adrenergic activity of imidazoline derivatives, Chemical Abstract, vol. 82, No. 17, (Apr. 28, 1975), p. 13.
Gellai et al, Renal Effects of Selective Alpha-1 and Alpha-2 Adrenoceptor Agonists in Conscious, Normotensive Rats, Journal of Pharmcol & Experimental Therapeutics, 240, p. 723 (1987).
Fondacaro et al, Selective Alpha-2 Adrenoceptor Agonists Alter Fluid and Electrolyte Transport in Mammalian Small Intestine, Journal of Pharmcol. & Experimental Therapeutics, 247, p. 481 (1988).
Burke et al, Ocular Effects Of A Relatively Selective Alpha-2 agonist (UK-14, 304-18) in Cats, Rabbits and Monkeys, Current Eye Research, 5, p. 665 (1986).
Jumblatt et al, Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body, Current Eye Research, 6, p. 767 (1987).
Mittag, Ph.D., Ocular Effects of Selective Alpha-Adrenergic Agents: A New Drug Paradox?, Annals of Ophthalmology, p. 201, (Mar. 1983).
Gellai et al, Mechanism of Alpha-2-adrenoceptor agonist-induced diuresis, American Journal Physiology, p. F317, (1988).
Timmermans et al, Clonidine and some bridge analogues; cardiovascular effects and nuclear magnetic resonance data (H/C), Eur. J. Med. Chem. 15, p. 323 (1980).
Isom et al, Alpha-2-Adrenergic Receptors Accelerate Na/H Exchange in Neuroblastoma X Glioma Cells, J. Biol. Chem., 262, p. 6750 (1987).
Fielding et al, Clonidine: New Research in Psychotropic Drug Pharmacology from Medicinal Research Reviews, vol. 1, pp. 97-123 (1981).
Dharmsathaphorn, Alpha-2-Adrenergic Agonists: A Newer Class of Antidiarrheal Drug Gastroenterology 1986; 91:769-75.
Allergan Inc.
Jordan Kimberly
Uxa, Jr. Frank J.
Waddell Frederick E.
LandOfFree
(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511174